Patent · US Active

Oxadiazole derivatives

US8815919B2 · kind B2 · utility

0Cited by

1References

5Claims

0Family size

Assignee

MERCK SERONO SA · CH

Inventors

Anna Quattropani · Rolle, CH
Cyril Montagne · Ferney-Voltaire, FR
Wolfgang Sauer · Everberg, BE
Stefano Crosignani · Nivelles, BE
Agnes Bombrun · Paris, FR

Key dates

Filing date	Mar 29, 2010
Grant date	Aug 26, 2014
Priority date	—
Expiry date	Mar 31, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D271/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to oxadiazole compounds of formula I. The compounds are useful e.g. in the treatment of autoimmune disorders, such as multiple sclerosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.